Parenteral Drugs (India) (NSE:PDPL) OCF Yield %: 0.00 (As of Jun. 27, 2026)


NSE:PDPL Parenteral Drugs (India) Ltd NSE:PDPL
4 GF Score
Price ₹2.90
View Full Analysis

What is Parenteral Drugs (India) OCF Yield %?

Parenteral Drugs (India) NSE:PDPL 4 OCF Yield % is 0.00 as of Jun. 27, 2026. GuruFocus rates NSE:PDPL with a GF Score™ of 4/100.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Parenteral Drugs (India)'s Trailing 12-Month Cash Flow from Operations is ₹0.00 Mil, and Market Cap is ₹101.08 Mil. Therefore, Parenteral Drugs (India)'s OCF Yield % for today is 0.00%.

The historical rank and industry rank for Parenteral Drugs (India)'s OCF Yield % or its related term are showing as below:


NSE:PDPL's OCF Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 3.61
* Ranked among companies with meaningful OCF Yield % only.

Parenteral Drugs (India)'s OCF Margin % for the quarter that ended in Mar. 2022 was %.

Parenteral Drugs (India) OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Parenteral Drugs (India) OCF Yield % Related Terms

Parenteral Drugs (India) OCF Yield % Historical Data

* Premium members only.

The historical data trend for Parenteral Drugs (India)'s OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Parenteral Drugs (India) OCF Yield % Chart

Parenteral Drugs (India) Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 364.78 1,893.41 1,449.45 -1.18 -4.50

Parenteral Drugs (India) Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:PDPL
4GF Score
Parenteral Drugs (India) Ltd NSE:PDPL
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Parenteral Drugs (India) OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Parenteral Drugs (India)'s OCF Yield % for the fiscal year that ended in Mar. 2022 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-4.827 / 107.3376
=-4.50%

Parenteral Drugs (India)'s annualized OCF Yield % for the quarter that ended in Mar. 2022 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=0 * 4 / 107.3376
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of 0.00 mean?
Parenteral Drugs (India) (NSE:PDPL) has a OCF Yield % of 0.00 as of Jun. 27, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Parenteral Drugs (India) and its competitors.
Is Parenteral Drugs (India)'s OCF Yield % too high?
Parenteral Drugs (India)'s current OCF Yield % is 0.00. Overall, Parenteral Drugs (India) has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Parenteral Drugs (India)'s OCF Yield % compare to ZTS and CTLT?
Parenteral Drugs (India)'s OCF Yield % of 0.00 can be compared against companies in the Drug Manufacturers industry. The industry median OCF Yield % is 3.61. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.61, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Parenteral Drugs (India) and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Parenteral Drugs (India)'s current OCF Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Parenteral Drugs (India) stock overvalued right now?
Parenteral Drugs (India) (NSE:PDPL) has a current OCF Yield % of 0.00. The current OCF Yield % is 0.00. Parenteral Drugs (India)'s overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Parenteral Drugs (India) (NSE:PDPL), the current OCF Yield % is 0.00 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Parenteral Drugs (India) Business Description

Address Navlakha Crossing, A. B. Road, Shree Ganesh Chambers, Indore, MP, IND, 452001
Parenteral Drugs (India) Ltd is a pharmaceutical company. It is principally engaged in manufacturing pharmaceutical preparations. The company manufactures products in categories like intravenous (IV) fluids, oncology, anesthesia, and export products. Its IV fluids products include carbohydrates and electrolytes, diuretics, dialysis, and irrigation solution, anti-infective and anti-fungal, and other pharmaceutical products.
4GF Score

Get the complete analysis for NSE:PDPL

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2.90
Price